Real-World Efficacy and Safety of Off-Label Use of Immune Checkpoint Inhibitors (ICI) in Cancer: A Retrospective Cohort Study in Qatar

Introduction: Immunotherapy has been an attractive choice for cancer treatment based on an increased understanding of T cell biology and tumor immunology (1). The occurrence of Off-label prescribing in Oncology is higher than other disciplinaries for many reasons, such as difficulty to conduct studi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Drug safety 2022-10, Vol.45 (10), p.1300-1301
Hauptverfasser:	Abaza, S, Nasser, S, Abuyounis, M, Nounou, A, Rasul, K, Hamad, A, Elazzazy, S
Format:	Artikel
Sprache:	eng
Schlagworte:	Breast cancer Cancer Cohort analysis Colorectal cancer Colorectal carcinoma Data collection Effectiveness Electronic health records Electronic medical records FDA approval Health services Hepatocellular carcinoma Immune checkpoint inhibitors Immunology Immunotherapy Inhibitors Lymphocytes Lymphocytes T Patients Pembrolizumab Population studies Safety Thyroid Toxicity Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!